This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
T. Rowe Price (TROW) Q2 Earnings Beat Estimates, AUM Rises
by Zacks Equity Research
T. Rowe Price's (TROW) Q2 earnings reflect solid revenues and higher expenses.
T. Rowe Price (TROW) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
T. Rowe (TROW) delivered earnings and revenue surprises of 3.12% and 0.86%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
T. Rowe Price (TROW) Earnings Expected to Grow: What to Know Ahead of Q2 Release
by Zacks Equity Research
T. Rowe (TROW) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
What's in the Cards for Ares Capital (ARCC) in Q2 Earnings?
by Zacks Equity Research
Ares Capital's (ARCC) second-quarter 2021 results are expected to reflect the favorable impacts of an anticipated rise in interest income from investments.
Will Inflows Support T. Rowe Price's (TROW) Q2 Earnings?
by Zacks Equity Research
T. Rowe's (TROW) Q2 results likely to reflect favorable impact of net inflows and solid revenue performance.
What to Expect From Navient (NAVI) This Earnings Season?
by Zacks Equity Research
Navient's (NAVI) Q2 earnings are likely to reflect unfavorable impact of the low-rate environment and decreased non-interest income.
Is a Beat in the Cards for Huntington (HBAN) in Q2 Earnings?
by Zacks Equity Research
Huntington's (HBAN) Q2 earnings are likely to have been driven by improved fee income, partly negated by yield curve flattening and high expenses.
What's in Store for Affiliated Managers (AMG) in Q2 Earnings?
by Zacks Equity Research
Affiliated Managers (AMG) is expected to have recorded a decent improvement in asset balances in the second quarter of 2021.
Asset Growth Likely to Support Invesco (IVZ) in Q2 Earnings
by Zacks Equity Research
Invesco (IVZ) is expected to have recorded an improvement in asset balances in the second quarter of 2021.
Here's Why T. Rowe Price (TROW) is a Strong Momentum Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
IB to Aid Raymond James (RJF) Q3 Earnings as Trading Normalizes
by Zacks Equity Research
Strong IB performance is expected to have supported Raymond James' (RJF) fiscal Q3 earnings. Normalized trading and lower rates are likely to have been undermining factors.
Decent Bond Issuance Volume to Aid Moody's (MCO) Q2 Earnings
by Zacks Equity Research
Modest global bond issuance volume and continuous efforts to expand analytics business are expected to have supported Moody's (MCO) Q2 earnings.
Is a Beat in the Offing for Ameriprise (AMP) in Q2 Earnings?
by Zacks Equity Research
Improved advisor productivity is expected to have supported Ameriprise's (AMP) asset growth to some extent in the second quarter of 2021.
Why T. Rowe (TROW) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
T. Rowe (TROW) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Regions (RF) to Report Q2 Earnings: What's in the Offing?
by Zacks Equity Research
While a rise in card fees and market-driven revenues are likely to aid Region's (RF) top-line growth, muted loan growth and yield curve flattening in Q2 are expected to have been deterrents.
Is a Beat in Store for Ally Financial (ALLY) in Q2 Earnings?
by Zacks Equity Research
Ally Financial (ALLY) is expected to have recorded a decline in fee revenues in the second quarter of 2021.
JHG vs. TROW: Which Stock Is the Better Value Option?
by Zacks Equity Research
JHG vs. TROW: Which Stock Is the Better Value Option?
Is a Beat in the Offing for Zions (ZION) in Q2 Earnings?
by Zacks Equity Research
Despite soft loan demand, Zions (ZION) is expected to have witnessed a modest rise in interest income in the second quarter of 2021.
Fee Income Growth to Support Comerica's (CMA) Q2 Earnings
by Zacks Equity Research
Comerica's (CMA) Q2 earnings are likely to reflect benefits from higher non-interest income, while muted revenue growth might have played spoilsport amid low interest rates.
Why T. Rowe Price (TROW) is a Top Dividend Stock for Your Portfolio
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does T. Rowe Price (TROW) have what it takes? Let's find out.
If You Invested $1000 in T. Rowe Price a Decade Ago, This is How Much It'd Be Worth Now
by Zacks Equity Research
Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.
BEN or TROW: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
BEN vs. TROW: Which Stock Is the Better Value Option?
This is Why T. Rowe Price (TROW) is a Great Dividend Stock
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does T. Rowe Price (TROW) have what it takes? Let's find out.
T. Rowe Price (TROW) Rewards Investors With Special Dividend
by Zacks Equity Research
T. Rowe Price (TROW) announces a special dividend. Should you consider adding the stock to your portfolio based on dividend income?
T. Rowe Price (TROW) May AUM Flat Sequentially at $1.59T
by Zacks Equity Research
T. Rowe Price's (TROW) efforts to launch funds and its business model diversity are likely to drive AUM growth, going forward.